Kyverna Therapeutics, Inc. Balance Sheet
Kyverna Therapeutics, Inc.'s total assets for Q3 2025 were $187.16M, a decrease of -17.37% from the previous quarter. KYTX total liabilities were $35.21M for the fiscal quarter, a -16.43% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.